These increased tumor and lymph node T: M ratios are most likely a result of increased availability of [89Zr]Zr-DFO-PD-L1 mAb in the blood due to the saturation of binding sites in the spleen with unlabeled PD-L1 mAb. This evidence concerns the gene CD274 and neoplasm.